Trevena to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
August 30 2018 - 4:30PM
Trevena, Inc. (NASDAQ:TRVN) today, announced it will be featured as
a presenting company at the 20th Annual Rodman & Renshaw Global
Investment Conference, sponsored by H.C. Wainwright & Co.,
LLC. on Wednesday, September 5, 2018 in New York, NY.
Event: 20th Annual Rodman & Renshaw Global Investment
Conference, sponsored by H.C. Wainwright & Co., LLC
Date: September 5, 2018
Time: 5:30p.m. EDT
Location: Library (2nd floor), St. Regis New York Hotel in New
York City
To join a live audio webcast of the presentation, please visit
the Investor section of the Company’s website. Following the
conclusion of the presentation, the webcast will be available for
replay for 30 days.
About Trevena
Trevena, Inc. is a biopharmaceutical company developing
innovative therapies based on breakthrough science to benefit
patients and healthcare providers confronting serious medical
conditions. The Company has discovered four novel and
differentiated drug candidates, including oliceridine injection,
currently under review by the U.S. Food and Drug Administration for
potential approval for the management of moderate-to-severe acute
pain, TRV250 for the treatment of acute migraine, and TRV734 for
pain. The Company maintains an early stage portfolio of drug
discovery programs.
Contacts
Trevena, Inc.http://www.trevena.com/index.php
Investors:
Jonathan Violin, Ph.D.Senior Vice President, Scientific Affairs
& Investor Relations Officer610-354-8840
x231jviolin@trevena.com
or
Media:
Public RelationsPR@trevena.com
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Sep 2023 to Sep 2024